Samuel Birer, MD
Radiation Oncology · Honolulu, HINPI 1679004014
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.0% of the total across 54 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 15.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $797 and has fallen 60.6% since, to $314 in 2025.
Across 54 payments — averaging $34.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$296
- Regeneron Healthcare Solutions, Inc.$279
- Elekta, Inc.$211
- Johnson & Johnson$143
- Janssen Scientific Affairs, LLC$126
- E.r. Squibb & Sons, L.L.C.$101
- plus $728 from 21 others
What the payments were for
- Food & beverage$1,82797%
- Education$563%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 7 | $296 |
| Regeneron Healthcare Solutions, Inc. | 4 | $279 |
| Elekta, Inc. | 2 | $211 |
| Johnson & Johnson | 5 | $143 |
| Janssen Scientific Affairs, LLC | 1 | $126 |
| E.r. Squibb & Sons, L.L.C. | 5 | $101 |
| Novartis | 4 | $97 |
| Novocure Inc. | 1 | $76 |
| Merck | 3 | $73 |
| Bayer | 3 | $72 |
| Reflexion Medical, Inc. | 1 | $41 |
| AbbVie | 1 | $34 |
| Genmab U.S., Inc. | 1 | $34 |
| Fresenius Kabi USA, LLC | 1 | $32 |
| Visionrt, Inc. | 2 | $27 |
| Ipsen Biopharmaceuticals, Inc | 1 | $25 |
| Eisai Inc. | 1 | $25 |
| Servier Pharmaceuticals LLC | 1 | $23 |
| Genentech USA, Inc. | 1 | $23 |
| Pfizer | 1 | $21 |
| Impedimed, Inc. | 1 | $20 |
| Sanofi | 1 | $19 |
| Sobi, Inc | 1 | $19 |
| Seagen Inc. | 1 | $18 |
| Iovance Biotherapeutics, Inc. | 2 | $17 |
| Incyte Corporation | 1 | $15 |
| Siemens Medical Solutions USA, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ELEKTA MEDICAL LINEAR ACCELERATOR$136
- RYBREVANT$126
- IMFINZI$125
- LIBTAYO$125
How this compares
$1,883 in reported general payments places this provider in the 70th percentile of 27 radiation oncology providers in Hawaii.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other radiation oncology in Honolulu
- Laeton PangHonolulu$10K
- Michael RoachHonolulu$9K
- Jared HaraHonolulu$3K
- Anthony MichaudHonolulu$3K
- John LedererHonolulu$3K
- Mark MayedaHonolulu$2K
- Christina SpeirsHonolulu$2K
- Richard LeeHonolulu$2K
- Scott MoonHonolulu$2K
- Susie ChenHonolulu$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.